Gastrointestinal effects: Mounjaro commonly causes gastrointestinal side effects, including nausea, vomiting, diarrhoea, and reduced appetite, particularly when starting treatment or increasing the dose
51 Park et al 52 found that empagliflozin, dulaglutide and a combination of both significantly attenuated the increase in cells, especially macrophages and neutrophils, in airway alveolar lavage fluid induced by a high-fat diet in mice, reduced the expression of IL-17 and transforming growth factor (TGF)-1, and decreased the differentiation of Th cells to Th1 and Th17, thereby achieving a reduced inflammatory response
doi: 10.1016/j.bpj.2010.07.063 96
In their lyophilised (freeze-dried) form, many peptides can remain stable at room temperature for short periods, although cooler conditions are always preferred
Insight Focus Global GLP-1 drug uptake has been limited by high cost and low availability
3) Botulinum Toxin (CG033, Ver